NephroWorldCup 2022: Metformin or SGLT2i in CKD patients with Diabetes Published 2022-08-29 Download video MP4 360p Recommendations 17:20 2022 NephroWorldCup: Management of Hyponatremia 08:55 NephroWorldCup: Kidney benefits of GLP1RA 08:15 SGLT2 Inhibitors and Heart Failure 15:34 SGLT2 Inhibitors vs GLP-1 Agonists: A Cardiologist and an Endocrinologist Weigh In 24:23 How to Avoid Blood Sugar Spikes (Without Reducing Carb Intake) 06:57 How does Dapagliflozin work? Understanding SGLT2 inhibitors. 10:49 Efficacy of tolvaptan on advanced chronic kidney disease with heart failure 53:35 The Challenges of Twitter-based Medical Education: A data-driven specialty-specific introspection 08:20 Renal Nutcracker Syndrome 33:16 Does protein in urine mean kidney damage? Are bubbles in urine normal? 08:11 NephroWorldCup 2022: Ketoanalogues in Chronic Kidney Disease 09:55 (ES) ROTATE-3 trial: NephroWorldCup 2022 03:45 NephroWorldCup 2022: Icosapent Ethyl in CKD 22:19 3 Essential Blood Tests To Run: you need to know this | Episode 4 of 18 10:30 Renal Pharmacists - NephroWorldCup 07:19 Renal Cell Carcinoma and CKD: NephroWorldCup 14:45 Hemochromatosis - My Iron Overload Story (2019) 15:34 I Have Type 1 Diabetes | Diagnosis Story 05:09 Renal iNUT Tool Similar videos 09:56 The consideration in using SGLT2 inhibitors in patients with CKD 08:37 Prof. Wael Farag -Initial Therapy for Type II Diabetes SGLT2 VS Metformin. 21:41 Dapaglifozin: SGLT2 inhibitor retarding progression of Diabetic kidney disease ( Me as a speaker) 23:20 How to prescribe metformin to CKD patients Renoprotection of metformin 07:23 ESC Guidelines: Prescribing SGLT2 inhibitors (English Version) 01:50 Beyond Metformin: Diabetes drugs as anti-aging targets | Dr. Nir Barzilai 57:11 week 2 - May CoPM Weekly Webinar 2022 - nephrology 1:14:56 De Fronzo and SGLT2 12:03 WONDER drugs or BLUNDER drugs. SGLT2 Inhibitors in Diabetes like Dapaglifozin or Empagliflozin 56:21 SGLT2 inhibitors in HFpEF (EMPEROR-Preserved Trial) 21:44 Dr. S. Arulrhaj Speaks on the topic "Cardio Diabetic Blockbuster - SGLT2i" | GCDC2022 Highlights 03:55 SGLT2 inhibitors in cancer patients 37:54 ROL DE SGLT2 i - GLP1 EN TRATAMIENTO DE DM2 52:01 Cardiovascular Risk Reduction with SGLT2 inhibitors and GLPl Agonists 1:18:55 Q & A Session on FDC of SGLT2 Inhibitors + DPP4 Inhibitors, Dapagliflozin 10mg + Sitagliptin 100 mg 03:54 Positive Overall Survival Rate in Patients With Advanced Pancreatic Cancer Treated On Metformin For 34:37 Christopher Cannon: Diabetes and Cardiovascular Disease. 01:00 USO ERRADO DE SGLT2 More results